Clinical Trial Update: A Clinical Trial to Evaluate the Safety and Efficacy of Neuromodulation Using 'ExAblate 4000 Type 2.1' in Patients With Psychostimulant Use Disorder(PUD) [NA]

View source ↗

Summary

A clinical trial is evaluating the safety and efficacy of neuromodulation using ExAblate 4000 Type 2.1 in patients with stimulant use disorder; the study is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stimulant Use Disorder

Drugs mentioned

• ExAblate 4000 Type 2.1

Snippet

Sponsor: Korea University Anam Hospital | Conditions: Psychostimulant Use Disorder(PUD) | NA | Status: RECRUITING